TY  - GEN
AU  - Kimura,Hideharu
AU  - Kasahara,Kazuo
AU  - Shibata,Kazuhiko
AU  - Sone,Takashi
AU  - Yoshimoto,Akihiro
AU  - Kita,Toshiyuki
AU  - Ichikawa,Yukari
AU  - Waseda,Yuko
AU  - Watanabe,Kazuyoshi
AU  - Shiarasaki,Hiroki
AU  - Ishiura,Yoshihisa
AU  - Mizuguchi,Masayuki
AU  - Nakatsumi,Yasuto
AU  - Kashii,Tatsuhiko
AU  - Kobayashi,Masashi
AU  - Kunitoh,Hideo
AU  - Tamura,Tomohide
AU  - Nishio,Kazuto
AU  - Fujimura,Masaki
AU  - Nakao,Shinji
TI  - EGFR mutation of tumor and serum in gefitinib-treated patients with chemotherapy-naive non-small cell lung cancer
SN  - 1556-1380
PY  - 2007///0502
KW  - Adenocarcinoma
KW  - drug therapy
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents
KW  - adverse effects
KW  - Biomarkers, Tumor
KW  - blood
KW  - Carcinoma, Large Cell
KW  - Carcinoma, Non-Small-Cell Lung
KW  - Carcinoma, Squamous Cell
KW  - DNA
KW  - ErbB Receptors
KW  - genetics
KW  - Exons
KW  - Female
KW  - Gefitinib
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Mutation
KW  - Polymerase Chain Reaction
KW  - Quinazolines
N1  - Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study
UR  - https://doi.org/10.1016/s1556-0864(15)31577-x
ER  -